SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001391045-15-000005
Filing Date
2015-11-12
Accepted
2015-11-12 11:56:51
Documents
1
Period of Report
2015-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_144734740069183.html 4  
1 FORM 4 wf-form4_144734740069183.xml 4 3336
  Complete submission text file 0001391045-15-000005.txt   4810
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Issuer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address P.O. BOX 1028 C/O STONE MANAGEMENT LLC BERWYNE PA 19312
Business Address
Legault Pierre (Reporting) CIK: 0001391045 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36303 | Film No.: 151222791